Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 528

1.

Nocardia colonization in contrast to nocardiosis: a comparison of patients' clinical characteristics.

Margalit I, Muhsen K, Ben Ari Y, Ben-Zvi H, Shostak Y, Krause I, Goldberg E.

Eur J Clin Microbiol Infect Dis. 2019 Dec 20. doi: 10.1007/s10096-019-03796-5. [Epub ahead of print]

PMID:
31863237
2.

Enhanced Glutamatergic Currents at Birth in Shank3 KO Mice.

Chiesa M, Nardou R, Lozovaya N, Eftekhari S, Tyzio R, Guimond D, Ferrari DC, Ben-Ari Y.

Neural Plast. 2019 Jul 3;2019:2382639. doi: 10.1155/2019/2382639. eCollection 2019.

3.

Early alterations in a mouse model of Rett syndrome: the GABA developmental shift is abolished at birth.

Lozovaya N, Nardou R, Tyzio R, Chiesa M, Pons-Bennaceur A, Eftekhari S, Bui TT, Billon-Grand M, Rasero J, Bonifazi P, Guimond D, Gaiarsa JL, Ferrari DC, Ben-Ari Y.

Sci Rep. 2019 Jun 25;9(1):9276. doi: 10.1038/s41598-019-45635-9.

4.

Striatal dual cholinergic /GABAergic transmission in Parkinson disease: friends or foes?

Lozovaya N, Ben-Ari Y, Hammond C.

Cell Stress. 2018 May 27;2(6):147-149. doi: 10.15698/cst2018.06.142.

5.

Treatment Outcomes of Stenotrophomonas maltophilia Bacteremia in Critically Ill Children: A Multicenter Experience.

Tokatly Latzer I, Nahum E, Cavari Y, Lazar I, Ben-Ari Y, Ben-Shimol S, Ben-Shalom G, Geffen Y, Goldberg L, Rubinstein M, Keller N, Pessach IM, Paret G.

Pediatr Crit Care Med. 2019 May;20(5):e231-e239. doi: 10.1097/PCC.0000000000001919.

PMID:
31058792
6.

Pyramidal neuron growth and increased hippocampal volume during labor and birth in autism.

Cloarec R, Riffault B, Dufour A, Rabiei H, Gouty-Colomer LA, Dumon C, Guimond D, Bonifazi P, Eftekhari S, Lozovaya N, Ferrari DC, Ben-Ari Y.

Sci Adv. 2019 Jan 23;5(1):eaav0394. doi: 10.1126/sciadv.aav0394. eCollection 2019 Jan.

7.

The GABA Developmental Shift Is Abolished by Maternal Immune Activation Already at Birth.

Fernandez A, Dumon C, Guimond D, Tyzio R, Bonifazi P, Lozovaya N, Burnashev N, Ferrari DC, Ben-Ari Y.

Cereb Cortex. 2019 Aug 14;29(9):3982-3992. doi: 10.1093/cercor/bhy279.

PMID:
30395185
8.

Oxytocin and Vasopressin, and the GABA Developmental Shift During Labor and Birth: Friends or Foes?

Ben-Ari Y.

Front Cell Neurosci. 2018 Aug 21;12:254. doi: 10.3389/fncel.2018.00254. eCollection 2018.

9.

Maturation of GABAergic Transmission in Cerebellar Purkinje Cells Is Sex Dependent and Altered in the Valproate Model of Autism.

Roux S, Lohof A, Ben-Ari Y, Poulain B, Bossu JL.

Front Cell Neurosci. 2018 Jul 30;12:232. doi: 10.3389/fncel.2018.00232. eCollection 2018.

10.

Term or Preterm Cesarean Section Delivery Does Not Lead to Long-term Detrimental Consequences in Mice.

Chiesa M, Guimond D, Tyzio R, Pons-Bennaceur A, Lozovaya N, Burnashev N, Ferrari DC, Ben-Ari Y.

Cereb Cortex. 2019 Jun 1;29(6):2424-2436. doi: 10.1093/cercor/bhy112.

PMID:
29771287
11.

GABAergic inhibition in dual-transmission cholinergic and GABAergic striatal interneurons is abolished in Parkinson disease.

Lozovaya N, Eftekhari S, Cloarec R, Gouty-Colomer LA, Dufour A, Riffault B, Billon-Grand M, Pons-Bennaceur A, Oumar N, Burnashev N, Ben-Ari Y, Hammond C.

Nat Commun. 2018 Apr 12;9(1):1422. doi: 10.1038/s41467-018-03802-y.

12.

Bumetanide for autism: more eye contact, less amygdala activation.

Hadjikhani N, Åsberg Johnels J, Lassalle A, Zürcher NR, Hippolyte L, Gillberg C, Lemonnier E, Ben-Ari Y.

Sci Rep. 2018 Feb 26;8(1):3602. doi: 10.1038/s41598-018-21958-x.

13.

Pharmacokinetic and pharmacodynamic evaluation of 5-methoxy-2-aminoindane (MEAI): A new binge-mitigating agent.

Shimshoni JA, Sobol E, Golan E, Ben Ari Y, Gal O.

Toxicol Appl Pharmacol. 2018 Mar 15;343:29-39. doi: 10.1016/j.taap.2018.02.009. Epub 2018 Feb 16.

PMID:
29458138
14.

NKCC1 Chloride Importer Antagonists Attenuate Many Neurological and Psychiatric Disorders.

Ben-Ari Y.

Trends Neurosci. 2017 Sep;40(9):536-554. doi: 10.1016/j.tins.2017.07.001. Epub 2017 Aug 14. Review.

PMID:
28818303
15.

Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders.

Lemonnier E, Villeneuve N, Sonie S, Serret S, Rosier A, Roue M, Brosset P, Viellard M, Bernoux D, Rondeau S, Thummler S, Ravel D, Ben-Ari Y.

Transl Psychiatry. 2017 May 9;7(5):e1124. doi: 10.1038/tp.2017.101. No abstract available.

16.

Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders.

Lemonnier E, Villeneuve N, Sonie S, Serret S, Rosier A, Roue M, Brosset P, Viellard M, Bernoux D, Rondeau S, Thummler S, Ravel D, Ben-Ari Y.

Transl Psychiatry. 2017 Mar 14;7(3):e1056. doi: 10.1038/tp.2017.10. Erratum in: Transl Psychiatry. 2017 May 9;7(5):e1124.

17.

Distribution and Dispersal of Phlebotomus papatasi (Diptera: Psychodidae) in a Zoonotic Cutaneous Leishmaniasis Focus, the Northern Negev, Israel.

Orshan L, Elbaz S, Ben-Ari Y, Akad F, Afik O, Ben-Avi I, Dias D, Ish-Shalom D, Studentsky L, Zonstein I.

PLoS Negl Trop Dis. 2016 Jul 18;10(7):e0004819. doi: 10.1371/journal.pntd.0004819. eCollection 2016 Jul.

18.

Failure of the Nemo Trial: Bumetanide Is a Promising Agent to Treat Many Brain Disorders but Not Newborn Seizures.

Ben-Ari Y, Damier P, Lemonnier E.

Front Cell Neurosci. 2016 Apr 14;10:90. doi: 10.3389/fncel.2016.00090. eCollection 2016.

19.

Pathogen receptor discovery with a microfluidic human membrane protein array.

Glick Y, Ben-Ari Y, Drayman N, Pellach M, Neveu G, Boonyaratanakornkit J, Avrahami D, Einav S, Oppenheim A, Gerber D.

Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):4344-9. doi: 10.1073/pnas.1518698113. Epub 2016 Apr 4.

20.

Treating Schizophrenia With the Diuretic Bumetanide: A Case Report.

Lemonnier E, Lazartigues A, Ben-Ari Y.

Clin Neuropharmacol. 2016 Mar-Apr;39(2):115-7. doi: 10.1097/WNF.0000000000000136.

PMID:
26966887
21.

Progress in autism research and postgenomic studies.

Ben-Ari Y.

Lancet Neurol. 2016 Feb;15(2):136. doi: 10.1016/S1474-4422(15)00402-0. Epub 2016 Jan 12. No abstract available.

PMID:
28463118
22.

Bumetanide to Treat Parkinson Disease: A Report of 4 Cases.

Damier P, Hammond C, Ben-Ari Y.

Clin Neuropharmacol. 2016 Jan-Feb;39(1):57-9. doi: 10.1097/WNF.0000000000000114.

PMID:
26757306
23.

Commentary: GABA depolarizes immature neurons and inhibits network activity in the neonatal neocortex in vivo.

Ben-Ari Y.

Front Cell Neurosci. 2015 Dec 16;9:478. doi: 10.3389/fncel.2015.00478. eCollection 2015. No abstract available.

24.

Is birth a critical period in the pathogenesis of autism spectrum disorders?

Ben-Ari Y.

Nat Rev Neurosci. 2015 Aug;16(8):498-505. doi: 10.1038/nrn3956. Epub 2015 Jul 8. Review.

PMID:
26152864
25.

Synapses as therapeutic targets for autism spectrum disorders: an international symposium held in pavia on july 4th, 2014.

Curatolo P, Ben-Ari Y, Bozzi Y, Catania MV, D'Angelo E, Mapelli L, Oberman LM, Rosenmund C, Cherubini E.

Front Cell Neurosci. 2014 Sep 29;8:309. doi: 10.3389/fncel.2014.00309. eCollection 2014. Review.

26.

Response to Comment on "Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring".

Eftekhari S, Shahrokhi A, Tsintsadze V, Nardou R, Brouchoud C, Conesa M, Burnashev N, Ferrari DC, Ben-Ari Y.

Science. 2014 Oct 10;346(6206):176. doi: 10.1126/science.1256009.

27.

The GABA excitatory/inhibitory developmental sequence: a personal journey.

Ben-Ari Y.

Neuroscience. 2014 Oct 24;279:187-219. doi: 10.1016/j.neuroscience.2014.08.001. Epub 2014 Aug 26. Review.

28.

Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model.

Lozovaya N, Gataullina S, Tsintsadze T, Tsintsadze V, Pallesi-Pocachard E, Minlebaev M, Goriounova NA, Buhler E, Watrin F, Shityakov S, Becker AJ, Bordey A, Milh M, Scavarda D, Bulteau C, Dorfmuller G, Delalande O, Represa A, Cardoso C, Dulac O, Ben-Ari Y, Burnashev N.

Nat Commun. 2014 Aug 1;5:4563. doi: 10.1038/ncomms5563.

29.

Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring.

Tyzio R, Nardou R, Ferrari DC, Tsintsadze T, Shahrokhi A, Eftekhari S, Khalilov I, Tsintsadze V, Brouchoud C, Chazal G, Lemonnier E, Lozovaya N, Burnashev N, Ben-Ari Y.

Science. 2014 Feb 7;343(6171):675-9. doi: 10.1126/science.1247190.

PMID:
24503856
30.

Improving emotional face perception in autism with diuretic bumetanide: a proof-of-concept behavioral and functional brain imaging pilot study.

Hadjikhani N, Zürcher NR, Rogier O, Ruest T, Hippolyte L, Ben-Ari Y, Lemonnier E.

Autism. 2015 Feb;19(2):149-57. doi: 10.1177/1362361313514141. Epub 2013 Dec 16.

PMID:
24343334
31.

Neuropaediatric and neuroarchaeology: understanding development to correct brain disorders.

Ben-Ari Y.

Acta Paediatr. 2013 Apr;102(4):331-4. doi: 10.1111/apa.12161. No abstract available.

PMID:
23906430
32.

Tubacin prevents neuronal migration defects and epileptic activity caused by rat Srpx2 silencing in utero.

Salmi M, Bruneau N, Cillario J, Lozovaya N, Massacrier A, Buhler E, Cloarec R, Tsintsadze T, Watrin F, Tsintsadze V, Zimmer C, Villard C, Lafitte D, Cardoso C, Bao L, Lesca G, Rudolf G, Muscatelli F, Pauly V, Khalilov I, Durbec P, Ben-Ari Y, Burnashev N, Represa A, Szepetowski P.

Brain. 2013 Aug;136(Pt 8):2457-73. doi: 10.1093/brain/awt161. Epub 2013 Jul 5.

PMID:
23831613
33.

Mechanisms and effects of seizures in the immature brain.

Nardou R, Ferrari DC, Ben-Ari Y.

Semin Fetal Neonatal Med. 2013 Aug;18(4):175-84. doi: 10.1016/j.siny.2013.02.003. Epub 2013 May 21. Review.

PMID:
23702158
34.

Treating Fragile X syndrome with the diuretic bumetanide: a case report.

Lemonnier E, Robin G, Degrez C, Tyzio R, Grandgeorge M, Ben-Ari Y.

Acta Paediatr. 2013 Jun;102(6):e288-90. doi: 10.1111/apa.12235.

PMID:
23647528
35.

Microfluidic large scale integration of viral-host interaction analysis.

Ben-Ari Y, Glick Y, Kipper S, Schwartz N, Avrahami D, Barbiro-Michaely E, Gerber D.

Lab Chip. 2013 Jun 21;13(12):2202-9. doi: 10.1039/c3lc00034f. Epub 2013 May 3. Review.

PMID:
23645014
36.

The developing cortex.

Ben-Ari Y.

Handb Clin Neurol. 2013;111:417-26. doi: 10.1016/B978-0-444-52891-9.00045-2. Review.

PMID:
23622190
37.

Pioneer glutamatergic cells develop into a morpho-functionally distinct population in the juvenile CA3 hippocampus.

Marissal T, Bonifazi P, Picardo MA, Nardou R, Petit LF, Baude A, Fishell GJ, Ben-Ari Y, Cossart R.

Nat Commun. 2012;3:1316. doi: 10.1038/ncomms2318.

38.

A randomised controlled trial of bumetanide in the treatment of autism in children.

Lemonnier E, Degrez C, Phelep M, Tyzio R, Josse F, Grandgeorge M, Hadjikhani N, Ben-Ari Y.

Transl Psychiatry. 2012 Dec 11;2:e202. doi: 10.1038/tp.2012.124.

39.

Genetic diversity of the Eurasian Otter (Lutra lutra) population in Israel.

Cohen TM, Narkiss T, Dolev A, Ben-Ari Y, Kronfeld-Schor N, Guter A, Saltz D, Bar-Gal GK.

J Hered. 2013 Mar;104(2):192-201. doi: 10.1093/jhered/ess094. Epub 2012 Dec 5.

PMID:
23225879
40.

The Yin and Yen of GABA in Brain Development and Operation in Health and Disease.

Ben-Ari Y.

Front Cell Neurosci. 2012 Nov 9;6:45. doi: 10.3389/fncel.2012.00045. eCollection 2012. No abstract available.

41.

Refuting the challenges of the developmental shift of polarity of GABA actions: GABA more exciting than ever!

Ben-Ari Y, Woodin MA, Sernagor E, Cancedda L, Vinay L, Rivera C, Legendre P, Luhmann HJ, Bordey A, Wenner P, Fukuda A, van den Pol AN, Gaiarsa JL, Cherubini E.

Front Cell Neurosci. 2012 Aug 28;6:35. doi: 10.3389/fncel.2012.00035. eCollection 2012.

42.

Kainate and Temporal Lobe Epilepsies: 3 decades of progress.

Ben-Ari Y.

In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, editors. Jasper's Basic Mechanisms of the Epilepsies [Internet]. 4th edition. Bethesda (MD): National Center for Biotechnology Information (US); 2012.

43.

Timing of developmental sequences in different brain structures: physiological and pathological implications.

Dehorter N, Vinay L, Hammond C, Ben-Ari Y.

Eur J Neurosci. 2012 Jun;35(12):1846-56. doi: 10.1111/j.1460-9568.2012.08152.x. Review.

PMID:
22708595
44.

The GABA excitatory/inhibitory shift in brain maturation and neurological disorders.

Ben-Ari Y, Khalilov I, Kahle KT, Cherubini E.

Neuroscientist. 2012 Oct;18(5):467-86. Epub 2012 Apr 30. Review.

PMID:
22547529
45.

Blocking seizures with the diuretic bumetanide: promises and pitfalls.

Ben-Ari Y.

Epilepsia. 2012 Feb;53(2):394-6. doi: 10.1111/j.1528-1167.2011.03378.x. Review. No abstract available.

46.

Is it safe to use a diuretic to treat seizures early in development ?

Ben-Ari Y, Tyzio R.

Epilepsy Curr. 2011 Nov;11(6):192-5. doi: 10.5698/1535-7511-11.6.192.

47.

Enhanced Synaptic Activity and Epileptiform Events in the Embryonic KCC2 Deficient Hippocampus.

Khalilov I, Chazal G, Chudotvorova I, Pellegrino C, Corby S, Ferrand N, Gubkina O, Nardou R, Tyzio R, Yamamoto S, Jentsch TJ, Hübner CA, Gaiarsa JL, Ben-Ari Y, Medina I.

Front Cell Neurosci. 2011 Nov 1;5:23. doi: 10.3389/fncel.2011.00023. eCollection 2011.

48.

Phenobarbital but Not Diazepam Reduces AMPA/kainate Receptor Mediated Currents and Exerts Opposite Actions on Initial Seizures in the Neonatal Rat Hippocampus.

Nardou R, Yamamoto S, Bhar A, Burnashev N, Ben-Ari Y, Khalilov I.

Front Cell Neurosci. 2011 Jul 28;5:16. doi: 10.3389/fncel.2011.00016. eCollection 2011.

49.

Excitatory action of GABA on immature neurons is not due to absence of ketone bodies metabolites or other energy substrates.

Ben-Ari Y, Tyzio R, Nehlig A.

Epilepsia. 2011 Sep;52(9):1544-58. doi: 10.1111/j.1528-1167.2011.03132.x. Epub 2011 Jun 21. Review.

50.

The immature brain needs GABA to be excited and hyper-excited.

Cherubini E, Ben-Ari Y.

J Physiol. 2011 May 15;589(Pt 10):2655-6. doi: 10.1113/jphysiol.2011.208884. No abstract available.

Supplemental Content

Loading ...
Support Center